Our mission is to not only raise awareness of Dementia, but funds for vital research. To date, we’ve been fortunate enough to support 6 research projects.
To find our more about being a recipient of grant funding to help with research please email us.
A tau-associated factor to enhance memory function
Dr Kristie Stefanoska; Molecular Dementia and Memory Research Lab at Flinders University
The research is investigating how tau-induced brain cell death contributes to cognitive decline. Dr Stefanoska is aiming to establish whether a protein called NSF could be a therapeutic target to reduce the detrimental effects of tau and protect neurons from its toxicity. Read more here.
Tau Protein Project
Dr Leah Beauchamp; The Florey Institute of Neuroscience and Mental Health
The buildup of toxic proteins in the brain contribute to the degenerative symptoms of Dementia. Dr Leah Beauchamp is investigating one of these specific proteins, the Tau protein, and how it can be cleared from the brain. She’s also focusing her research on another protein that’s impacted by Tau, and how it can be reactivated so it can do its job.
The Blood Brain Barrier Project
Dr Dorothy Wai; Monash University
With no effective treatment for dementia currently available, Dr Wai is able to use her grant to continue vital research into finding a drug that could one day offer a cure. What’s known as the blood-brain barrier, has so far prevented drugs from working, but Dr Wai hopes her research will enable drugs to cross this threshold.
Dr Janet Van Eersel; The Dementia Research Centre (DRC) Macquarie University
The new funding given to Dr Janet Van Eersel will enable her team in the Dementia Research Centre at Macquarie University to continue their research into key dementia-causing proteins, and hopefully find a cure.
Cage vs Age
Dr Andrew Care and Miss India Boyton; University of Technology Sydney
The research project, Cage vs Age was funded in 2019. Thanks to this grant, Dr Andrew Care and Miss India Boyton from were able to continue their research of the pTau protein in the brain with the development of an innovative nanotechnology to hopefully stop its spread to the advancement of Alzheimer’s disease.